Skip to main content
OpenTrials
Completed

NCT Number: NCT07480135

Pain Experience Using Lidocaine Adrenaline Tetracaine (LAT) Gel Versus Lidocaine Infiltration for Laceration Repair in Adults

This prospective comparative study evaluates pain experience in adult patients undergoing laceration repair in the emergency department using either topical lidocaine-adrenaline-tetracaine (LAT) gel or lidocaine infiltration as local anaesthesia. Lidocaine infiltration is the standard anaesthetic technique for wound repair but can cause significant pain during injection. LAT gel is a needle-free topical anaesthetic that is widely used in paediatric patients but has been less studied in adults.

Adult patients presenting with simple lacerations requiring suturing are allocated to receive either LAT gel or lidocaine infiltration according to the clinical judgement of the treating physician. Pain is measured using a visual analogue scale (VAS) during anaesthetic administration, during testing of anaesthetic effectiveness, and during suturing. Additional variables include wound characteristics, patient characteristics, and the need for additional anaesthesia. The study aims to evaluate whether LAT gel provides comparable pain control while reducing pain during anaesthetic administration.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Department of Emergency Medicine, Universitair Ziekenhuis Brussel, and Research Group on Emergency and Disaster Medicine

Jette, Brussels Capital, 1090, Belgium

About this study

Pain management is an important component of wound treatment in the emergency department. Local anaesthesia is routinely required for laceration repair, most commonly using infiltrative anaesthesia with lidocaine. Although effective, lidocaine infiltration can cause significant discomfort due to the injection itself and may increase patient anxiety. In addition, infiltration can sometimes distort tissue and potentially complicate the suturing procedure. Alternative approaches that reduce pain during anaesthetic administration may therefore improve patient comfort during wound management.

Topical anaesthesia using lidocaine-adrenaline-tetracaine (LAT) gel represents a needle-free alternative to infiltrative anaesthesia. LAT gel is commonly used in paediatric patients and has demonstrated effectiveness in reducing pain during laceration repair. However, evidence regarding its use in adult patients remains limited. Evaluating the effectiveness of LAT gel in adults may help determine whether it can be used more broadly as an alternative to injection-based anaesthesia in the emergency department.

This prospective comparative study includes adult patients presenting to the emergency department of Universitair Ziekenhuis Brussel with simple lacerations requiring suturing. Patients receive either LAT gel or lidocaine infiltration as local anaesthesia according to the clinical judgement of the attending physician. Pain experience is measured using a visual analogue scale (VAS) during anaesthetic administration, during testing of anaesthetic adequacy, and during suturing. Additional variables recorded include patient characteristics, wound characteristics, suturing characteristics, the need for additional anaesthesia, and procedure-related complications. The aim of the study is to compare pain experience between both anaesthetic techniques and to assess whether LAT gel may represent a suitable alternative for selected adult lacerations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Presentation to the emergency department with a simple laceration requiring suturing
  • Laceration length less than 7 cm
  • Ability to provide informed consent
  • Ability to report pain using a visual analogue scale (VAS)

Exclusion criteria

  • Suspected tendon injury or nerve injury
  • Wounds located on mucosal surfaces
  • Wounds located on ears, nose, or genital area
  • Known allergy to local anaesthetic agents
  • Pregnancy
  • Severe cardiac or pulmonary disease
  • Drug intoxication or altered mental status
  • Sedation with nitrous oxide
  • Psychiatric disorder interfering with pain reporting
  • Language barrier preventing informed consent or pain assessment

Treatment and study plan

Lidocaine-Adrenaline-Tetracaine (LAT) Gel

Drug

LAT gel (lidocaine 4%, adrenaline 0.1%, tetracaine 0.5%) is applied directly into the wound at a dose of approximately 0.5 mL per centimetre of wound length and covered with an occlusive dressing for 30 minutes prior to suturing.

Lidocaine infiltration

Drug

Subcutaneous infiltration of lidocaine 1% is administered locally around the wound approximately 5 minutes prior to suturing.

Primary outcomes

  1. Pain during suturing

    Time frame: During suturing procedure

    Pain experienced during wound suturing measured using a 100 mm visual analogue scale (VAS).

Secondary outcomes

  1. Pain during anaesthetic administration

    Time frame: At time of anaesthetic administration

    Pain experienced during administration of the anaesthetic (LAT gel application or lidocaine infiltration) measured using a visual analogue scale (VAS).

  2. Pain during testing of anaesthetic effectiveness

    Time frame: After waiting period for anaesthesia (30 minutes LAT gel / 5 minutes lidocaine)

    Pain experienced during testing of anaesthetic adequacy using a needle prick, measured using a visual analogue scale (VAS).

Other outcomes

  1. Need for additional anaesthesia

    Time frame: During wound preparation prior to suturing

    Number of patients requiring additional lidocaine infiltration due to insufficient anaesthetic effect.

  2. Wound characteristics

    Time frame: At time of emergency department presentation

    Description of wound location and wound length.

Sponsors and collaborators

Lead sponsor

Vrije Universiteit Brussel

Other

Collaborators

  • Universitair Ziekenhuis Brussel

Registry information

Official study title

Pain Experience Using Lidocaine Adrenaline Tetracaine (LAT) Gel Versus Lidocaine Infiltration for Laceration Repair in Adults: a Prospective Comparative Study in the Emergency Department

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 18, 2026
Registry last updated
Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.